Brevetti EPO No.4531857 2026.03.11
Brevetti EPO
(10) Registration Number and Date
2026000311 2026.07.23
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2026/000311 2023.05.25
(40) Publication Number and Date
SM /T/2026/000311 2026.07.23
(30) Priority Details
US 202363443269 P
2023.02.03
US 202363455861 P
2023.03.30
US 202363440297 P
2023.01.20
US 202263345727 P
2022.05.25
(71/73) Applicant
(IT) HIBERCELL, INC. : 619 West 54th Street, 8th Floor, New York, NY 10019, US
(72) Inventor
(IT) BOSE, Nandita : , New York, New York 10019, US
(IT) TAMEIRE, Feven : , New York, New York 10019, US
(IT) IGLESIAS, Jose : , New York, New York 10019, US
(IT) SURGULADZE, David : , New York, New York 10019, US
(IT) MULVIHILL, Mark J. : , New York, New York 10019, US
(IT) GARGANO, Michele : , New York, New York 10019, US
(74) Representative Name
(IT) FERRIERO, Paolo : Via del Serrone, 109, 47897 Fiorentino RSM, SM
(54) Title
(IT) MODULATORE DI GCN2 PER IL TRATTAMENTO DI TUMORI SOLIDI AVANZATI O CANCRO DEL SANGUE
(EN) GCN2 MODULATOR FOR TREATING ADVANCED SOLID TUMORS OR BLOOD CANCER
(57) Abstract
(58) Citations